In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks discussing Journavx (suzetrigine), recommendations for vitamin D and calcium supplementation, perioperative use of tapentadol, and more!
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain, Published as an FDA News Release, January 2025
Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication, Published by the U.S. Preventive Services Task Force, December 2024
Considerations for perioperative opioid analgesic stewardship in Australia: a focus on tapentadol, Published in Pain Management, June 2023
The Overdose Crisis among U.S. Adolescents, Published in the New England Journal of Medicine, January 2024
Mortality Trends Among Early Adults in the United States, 1999-2023, Published in JAMA Network Open, January 2025
